International
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has seemingly committed to hosting a meeting there, but the concerns won’t abate
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Sponsored
Sponsored
-
Sponsored by NokiaManaging IP sat down with Clay Gaetje of Nokia’s New Segments Licensing team to discuss the wider technological benefits to be found in a robust licensing programme -
Sponsored by NokiaManaging IP sat down with Nokia’s head of multimedia technologies, Ville-Veikko Mattila, to discuss the cutting-edge applications of Versatile Video Coding, and the societal challenges that could be overcome via digital standardisation
-
Sponsored by ZaccoSenior reporter Max Walters is joined by Anders Fredriksson and Elmin Tutkur of IP firm Zacco to tackle the controversial topic of software patents
-
Sponsored by CASJoin Managing IP and CAS for a webinar on September 26 at 10am ET / 3pm BST / 4pm CET to discuss the exciting opportunities that AI offers for revolutionising patent searches
-
Sponsored by ZaccoSenior reporter Max Walters is joined by Hampus Adlerton and Thomas Mølsgaard of IP firm Zacco to discuss everything IP owners need to know about the latest topic on everyone’s lips – NFTs
-
Sponsored by IncoproHosted by Managing IP’s Ed Conlon, the discussion at Incopro’s Insync Virtual Summit explored how the pandemic has affected brand protection teams and offered key insights to drive success in 2021
